Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2021-04-01, Stock:LLY, The news for the past five days is as follows:
2021-03-25: NEWS1: Pfizer, Eli Lilly say experimental arthritis drug tanezumab hits FDA snag.NEWS2: U.S. stops distribution of Lilly's COVID-19 therapy due to impact of variants.NEWS3: Global Life Sciences CDMO Selects Kneat's e-Validation SaaS Platform.
2021-03-26: NEWS1: Pfizer (PFE) Gets Unfavorable Votes from FDA Panel for Tanezumab.NEWS2: Looking Into Eli Lilly's Return On Capital Employed.NEWS3: Pfizer And Eli Lilly's Osteoarthritis Drug Rejected By FDA Panel As Too Risky.
2021-03-29: NEWS1: Eli Lilly-Vir Bamlanivimab-VIR-7831 Combo Reduces Viral Load By 70% In Low-Risk COVID-19 Patients.NEWS2: UPDATE 1-Lilly-Vir's COVID-19 antibody combo reduces viral load in study.NEWS3: Eli Lilly, Vir and Glaxo say Phase 2 trial combining antibodies reduced viral load by 70% at day 7.NEWS4: Lilly, Vir Biotechnology and GSK Announce Positive Topline Data from the Phase 2 BLAZE-4 Trial Evaluating Bamlanivimab with VIR-7831 in Low-Risk Adults with COVID-19.NEWS5: This Stalwart's Growth Story Isn't Over Yet.
2021-03-30: NEWS1: Lilly/Vir's Cocktail COVID-19 Therapy Meets Study Endpoint.
2021-03-31: NEWS1: Survey reveals healthcare professionals believe greater collaboration is needed to improve patient outcomes in diabetes care.NEWS2: Could Pfizer's and Lilly's Long-Awaited Osteoarthritis Drug Flop?.

Answer: Decrease